As of 2025-12-22, the Relative Valuation of Inozyme Pharma Inc (INZY) is (17.65) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.00 USD, the upside of Inozyme Pharma Inc based on Relative Valuation is -541.1%.
The range of the Relative Valuation is (12.66) - (23.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 5.2x - 14.5x | 9.9x |
| Forward P/E multiples | 7.7x - 15.3x | 11.5x |
| Fair Price | (12.66) - (23.97) | (17.65) |
| Upside | -416.5% - -699.2% | -541.1% |
| Date | P/E |